Investment KPCB Leads $30M Series B Round In Chinese 3D Printing Service Provider August 8, 2019 β 17:42
Interviews KPCB’s James Huang Says High Healthcare Valuations Force Investors To Seek Early Stage Innovation October 18, 2017 β 14:21
Exits Chinese Biopharma Firm Zai Lab Completes $150M US Listing, Shares Jump 55% September 21, 2017 β 12:20
KPCB, DT Capital Invest In Chinese Healthcare Firm Nurotron Biotechnology December 25, 2013 β 23:57
